Cell Therapies

Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
CGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentR&D project spotlight: Developing a smart bioprocessing platform integrating real-time process monitoring and advanced process control for autologous cell therapyR&D project spotlight: Developing a smart bioprocessing platform integrating real-time process monitoring and advanced process control for autologous cell therapyFrom nascent to mainstream: Overcoming barriers in iPSC therapy developmentFrom nascent to mainstream: Overcoming barriers in iPSC therapy developmentChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processChallenge Theme R&D spotlight: Development of an end-to-end closed iPSC expansion processPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesPlasticell, Cell and Gene Therapy Catapult and Imperial College London obtain funding to develop manufacturing platform for allogeneic cell immunotherapiesCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyCell and Gene Therapy Catapult to support the development of NK:IO’s natural killer cell therapyCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarterCell and Gene Therapy Catapult opens new laboratories and offices in Edinburgh BioQuarterPress Release: iPSC line licensed to Universal Cells to assist in the development of universal donor cell linePress Release: iPSC line licensed to Universal Cells to assist in the development of universal donor cell line